CCR-11 is an antibacterial agent that inhibits the proliferation of B. subtilis cells (IC50 = 1.2 μM) and HeLa cells (IC50 = 18.1 μM). It suppresses bacterial cytokinesis by inhibiting FtsZ assembly and can be used in research on FtsZ-targeted antibacterial drugs.